1 study found for:    SGN-CD33A
Show Display Options
Rank Status Study
1 Recruiting A Safety Study of SGN-CD33A in AML Patients
Conditions: Acute Myelogenous Leukemia;   Acute Myeloid Leukemia
Intervention: Drug: SGN-CD33A

Indicates status has not been verified in more than two years